#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypotransferrinaemia Endocrine ophthalmopathy Mitochondrial DNA depletion Mucous membrane pemphigoid Hairy cell leukaemia recurrent Inclusion body myositis Lymphangioma Neoplasm Cardiac amyloidosis Chronic cutaneous lupus erythematosus Mucopolysaccharidosis III Glycogen storage disease type II Graft versus host disease Renal cancer metastatic Prader-Willi syndrome More trials…

    Learn about Rare Diseases

    Choroid melanoma – Diagnostics Congenital nephrogenic diabetes insipidus – Diagnostics Friedreich’s ataxia – Treatment Factor VIII deficiency – Life with Disease Chondrosarcoma – Life with Disease Pulmonary sarcoidosis Haemophagocytic lymphohistiocytosis – Trials in Disease Angiosarcoma – Treatment Piriformis syndrome – Basic Information Splenic marginal zone lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fingolimod Cyclophosphamide Codeine Phosphate Hemihydrate Azd5863 Edotreotide Pentoxifylline TX000045 Amniotic Membrane, Human Fludrocortisone Acetate SODIUM FUSIDATE Doxorubicin Iloprost Trometamol Aspergillus Fumigatus L-ARGININE Ruxolitinib 99MTC-EUK-(SO3)CY5-MAS3 Diacerein Olaptesed Pegol Iti-1284 A/H1N1 INFLUENZA VACCINE More therapies…

    Learn about Your Condition

    Sepsis Obstructive airways disorder Renal transplant Skin ulcer Arteriovenous graft thrombosis Drug dependence Small for dates baby Vitiligo Andersen-Tawil syndrome Leukoencephalopathy Adrenoleukodystrophy Osteogenesis imperfecta Open angle glaucoma Metabolic syndrome Hereditary angioedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of caspofungin compared to placebo for treating yeast infections in the abdomen in intensive care unit patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Peritonitis
    • Fungal infection
    Investigated Drugs:
    • Caspofungin
    • Sodium Chloride
    France

  • Study on MK-2870, Pembrolizumab, and Chemotherapy for Patients with Advanced Gastroesophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    Investigated Drugs:
    • H2-Receptor Antagonist
    • Patritumab Deruxtecan
    • Sacituzumab Tirumotecan
    France Germany Italy Norway

  • Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Mitoxantrone Hydrochloride
    • Dexamethasone Ph. Eur.
    • Inotuzumab Ozogamicin
    Austria Belgium Czechia Denmark Finland France +10

  • Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Guselkumab
    Austria Belgium France Italy The Netherlands Norway +3

  • Study on Reducing Chemotherapy Cycles with Pembrolizumab for Patients with PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Fluorouracil
    France

  • Study of GS030 gene therapy safety and tolerability in patients with Retinitis Pigmentosa

    Recruiting

    1 1 1
    Investigated Diseases:
    • Retinitis pigmentosa
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 2.7M8 Containing The Chrimsonr-Tdtomato Gene
    France
Previous Page
1 … 339 340 341 342 343 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!